Cirrhosis and Liver Transplantation: Understanding Candidacy and Treatment Options in Katy, TX
A liver transplant may be considered when cirrhosis causes serious complications or liver failure, or for selected liver cancers. Referral starts an evaluation; it does not guarantee listing or surgery.
Key Takeaways
- A decompensating event can justify transplant referral even when one score seems modest.
- A transplant center assesses expected benefit, surgical risk, and the support needed for recovery.
- MELD helps assess illness severity and allocation priority, but it does not replace the full evaluation.
- Evaluation, acceptance, waitlisting, and transplantation are separate decisions.
- Ongoing cirrhosis treatment and surveillance continue during the evaluation and waiting period.
When cirrhosis prompts a transplant discussion
Cirrhosis may remain compensated for a time, meaning the liver is scarred without major decompensating complications. Ascites, hepatic encephalopathy, and variceal bleeding can mark a change in prognosis. These events should trigger a discussion about whether transplant evaluation is appropriate.
For Katy patients, local GI care can support monitoring and referral, while a transplant center makes candidacy and listing decisions. Review the cirrhosis overview and bring records of complications, hospitalizations, and previous treatment.
What a transplant evaluation considers
Liver disease trajectory
The team considers the cause of liver disease, prior complications, laboratory trends, and how quickly the situation is changing.
MELD assessment
MELD uses laboratory and other inputs to estimate short-term risk. A score informs decisions but does not capture every complication or need.
Cancer assessment
Selected HCC cases may be considered for transplant. Tumor features and transplant-center criteria determine eligibility.
Heart and lung health
Testing evaluates whether you can tolerate surgery and whether other conditions need treatment before a decision.
Kidneys and infection
Kidney function and active infections are assessed because they can affect timing, treatment, and the transplant plan.
Nutrition and strength
Frailty and muscle loss matter, but a single impression should not decide eligibility. Nutrition and rehabilitation may be part of preparation.
Support and medicines
The team discusses medication management, transportation, caregiving, follow-up access, and practical barriers that need support.
Alcohol and other substances
Individual evaluation may include addiction treatment and recovery support. Requirements vary; do not assume one universal waiting-period rule.
What referral guidance means in practice
AASLD/AST: Liver transplantation candidate evaluation guideline supports referral after decompensation and emphasizes multidisciplinary evaluation. MELD alone should not be used to block an otherwise appropriate referral.
The NIDDK transplant process guide describes referral and evaluation. Eligibility and listing policies must be confirmed directly with the selected transplant center.
The path from referral to a transplant decision
After a referral, the transplant team reviews medical records and arranges individualized testing and consultations. Ask which records, imaging studies, and screening tests should be sent before the first visit.
If accepted, the next steps depend on the donor pathway and current allocation rules. Deceased-donor allocation is based on medical priority and matching factors, not simply who joined the list first. A living-donor option requires separate donor evaluation.
No article can predict your wait time or acceptance. Ask the center how it evaluates benefit, what could delay listing, and how to report a change in health while the assessment is underway.
Understanding possible evaluation outcomes
A mental health diagnosis or physical frailty should not automatically be assumed to exclude someone. The evaluation should identify support and treatment needs and consider the complete clinical situation.
Evaluation proceeds
Complete the agreed testing and attend appointments. Keep local treatment and surveillance active while the transplant team reviews candidacy.
A barrier needs treatment
The team may request infection treatment, recovery support, rehabilitation, or other preparation before reassessment. Ask for a written plan and timeline.
Transplant is not advised
Discuss the reasons, whether reassessment is possible, and the best medical and supportive care options for your goals.
Care that continues before transplantation
Continue treatment for the cause of cirrhosis and its complications. This may include fluid management, encephalopathy therapy, bleeding prevention, nutrition support, and liver cancer surveillance. Medication changes should be coordinated between teams.
After transplant, long-term immunosuppressive medicines and follow-up are needed. Discuss infection risk, medication access, recovery help, and the possibility of disease recurrence. A transplant is a major treatment commitment rather than an immediate end to medical care.
Urgent changes during evaluation or waiting
Acute bleeding, confusion, fever with abdominal pain, or severe breathlessness needs urgent treatment. Do not wait for a transplant coordinator to return a routine message when symptoms are severe.
If hospitalized, tell both the local and transplant teams. New complications or updated laboratory results may affect the plan and need timely communication.
- Blood in vomit or black tarry stool
- New marked confusion, fainting, or severe breathlessness
- Fever with ascites pain or a major drop in urine output
Prepare for a transplant conversation
- Collect recent laboratory results, imaging, endoscopy, and discharge records.
- List complications and the dates they first occurred.
- Ask whether referral is indicated now and which center will receive it.
- Identify medication, transportation, nutrition, and caregiving needs early.
Frequently Asked Questions
Does everyone with cirrhosis need a transplant?
No. Some people remain stable with treatment and monitoring. Transplant is considered when expected benefit outweighs the risks in the individual situation.
Should I wait for a very high MELD score before asking about referral?
No. Decompensation or other important features can justify evaluation. A liver specialist can discuss referral even when MELD does not seem high.
Does a transplant referral mean I am on the waiting list?
No. Referral begins assessment. The transplant center must evaluate and accept a candidate before the relevant listing steps occur.
Can liver cancer qualify someone for transplant evaluation?
Selected HCC cases can qualify. The team considers tumor features, liver function, treatment response, and current transplant criteria.
Is there a universal six-month alcohol rule for every candidate?
Do not assume one rule applies to everyone. Transplant programs assess alcohol use, treatment, recovery support, and candidacy under their policies.
Can a person with low muscle strength be evaluated?
Yes. Frailty is an important risk factor but should not be the sole reason to deny evaluation. Assessment may include nutrition and rehabilitation planning.
Is the liver waiting list first come, first served?
No. Allocation uses medical priority, matching, and other current policy factors. Your center can explain how the rules apply to your case.
What should I keep doing while waiting for a decision?
Continue prescribed liver care, surveillance, nutrition support, and appointments. Report hospitalizations or new complications promptly to the teams involved.
Medical References
- AASLD/AST: Liver transplantation candidate evaluation guideline
- NIDDK: The liver transplant process
- AASLD: Outpatient management of cirrhosis
- NIDDK: Treatment for cirrhosis
This article provides general education for readers in Katy, TX. It does not replace an individual diagnosis or treatment plan. GastroDoxs sees patients ages 18 and older. In the United States, call 911 for a medical emergency.
Discuss Cirrhosis Care and Referral in Katy
Bring your liver records and hospitalization history to GastroDoxs. Review current complications and whether transplant-center evaluation should be part of your care plan.